SRRK - スカラ―・ロック・ホ―ルディング （Scholar Rock Holding Corporation）

https://www.investing.com/news/pro/piper-sandler-assumes-scholar-rock-at-overweight-432SI-3047368

Scholar Rock press release (NASDAQ:SRRK): FY GAAP EPS of -$2.26 beats by $0.02.Revenue of $33.19M (+76.4% Y/Y) in-line.

Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth f

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will present at the Cowen 43rd Annual Health Care Conference on Tuesday, March 7, 2023, at 12:50 p.m. ET. A live webcast of the presentation may be accessed by visiting the Investors & Media section of the Scholar Rock website at http://investors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; “The Company”), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that the Company granted inducement equity awards covering an aggregate of 285,000 shares of its common stock to two newly hired employees, consisting of inducement stock options to purchase an aggregate of 255,000 shares of common stock and induceme

Scholar Rock press release (SRRK): Q2 GAAP EPS of -$1.06 misses by $0.02.As of June 30, 2022, Scholar Rock had cash, cash equivalents, and marketable securities of approximately…

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today reported financial results and corporate updates for the second quarter ended June 30, 2022. “We are pleased to have reported important progress with our two clinical programs during the second quarter. Enrollment continues to advance in our pivotal Phase 3 SAPPHIRE trial for

Scholar Rock Holding Corporation (NASDAQ:SRRK) shares, rose in value on Friday, 08/05/22, with the stock price up by 21.26% to the previous day’s close as strong demand from buyers drove the stock to $8.50. Actively observing the price movement in the last trading, the stock closed the session at $7.01, falling within a range of … Scholar Rock Holding Corporation (NASDAQ: SRRK) Is An Exciting Stock To Watch. Read More »

During the last session, Scholar Rock Holding Corporation (NASDAQ:SRRK)’s traded shares were 0.45 million, with the beta value of the company hitting 0.56. At the end of the trading day, the stock’s price was $7.98, reflecting an intraday loss of -0.62% or -$0.05. The 52-week high for the SRRK share is $44.95, that puts it … We Just Learned Something New About Scholar Rock Holding Corporation (NASDAQ: SRRK) This Week With Its -4.77% Loss Read More »

Truist has initiated Scholar Rock Holding Corp (SRRK) with a buy citing the company''s validated platform that targeting growth factors for rare disease and oncology indications.

During the last session, Scholar Rock Holding Corporation (NASDAQ:SRRK)’s traded shares were 0.45 million, with the beta value of the company hitting 0.56. At the end of the trading day, the stock’s price was $7.98, reflecting an intraday loss of -0.62% or -$0.05. The 52-week high for the SRRK share is $44.95, that puts it … We Just Learned Something New About Scholar Rock Holding Corporation (NASDAQ: SRRK) This Week With Its -4.77% Loss Read More »

Truist has initiated Scholar Rock Holding Corp (SRRK) with a buy citing the company''s validated platform that targeting growth factors for rare disease and oncology indications.

NEW YORK , July 12, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INMD, EVFM, SRRK, VRCA, and INDO. … Full story available on Benzinga.com

Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN ) shares surged 69.5% to $2.1199 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change in patients'' clinical condition. Resolute Forest Products Inc. (NYSE: RFP ) shares jumped 63.9% to $20.47 after The Paper Excellence Group announced an agreement to acquire the company. SCWorx Corp. (NASDAQ: WORX ) jumped 52% to $0.9425 after the company reported a common stock purchase agreement with institutional investor on Tuesday. Enjoy Technology, Inc. (NASDAQ: ENJY ) jumped 50% to $0.4651 after jumping more than 80% on Tuesday. Kalera Public Limited Company (NASDAQ: KAL ) shares climbed 28.6% to $3.6001 after dipping 22% on Tuesday. Engine Gaming and Media, Inc. (NASDAQ: GAME ) gained 27.2% to $1.17. Engine Gaming and Media is expected to release fiscal third quarter results on Thursday, July 14, 2022. Sintx Technologies, Inc. (NASDAQ: SINT ) jumped 27% to $0.5210. SINTX Technologies earlier announced acquisition of Technology Assessment and Transfer, Inc.